Brief: Galecto Reports First Quarter Operating And Financial Results
Galecto Inc GLTO.O :
* GALECTO REPORTS FIRST QUARTER OPERATING AND FINANCIAL
RESULTS
* GALECTO INC - QTRLY LOSS PER SHARE $0.51
Source text for Eikon: ID:nGNX4hXDCc
Further company coverage: GLTO.O
Recent news on Damora Therapeutics
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Brief: Damora Therapeutics Reports First Quarter 2026 Financial Results
Brief: Damora Therapeutics: Lori Firmani To Cease Serving As CFO Effective May 1, 2026 - SEC Filing